Rui Wu

676 total citations
38 papers, 439 citations indexed

About

Rui Wu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Rui Wu has authored 38 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Rui Wu's work include Lymphoma Diagnosis and Treatment (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related gene regulation (5 papers). Rui Wu is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related gene regulation (5 papers). Rui Wu collaborates with scholars based in China, United States and Canada. Rui Wu's co-authors include Megan S. Lim, Jin‐Tang Dong, Wenbin Zheng, Thomas G. Gross, Anne F. Reilly, Catherine M. Bollard, Sarah Alexander, Donald A. Barkauskas, Eric Lowe and Lauren Saguilig and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Rui Wu

35 papers receiving 435 citations

Peers

Rui Wu
Jun Watanabe Japan
S. Gururangan United States
Rachel Chiaroni-Clarke Australia
Yan Yi China
Hirotomo Tanaka Japan
Meral Sakızlı Türkiye
Renata Ferri Italy
Susanna Mannisto Finland
Signe Ledou Nielsen Denmark
Jun Watanabe Japan
Rui Wu
Citations per year, relative to Rui Wu Rui Wu (= 1×) peers Jun Watanabe

Countries citing papers authored by Rui Wu

Since Specialization
Citations

This map shows the geographic impact of Rui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Wu more than expected).

Fields of papers citing papers by Rui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Wu. The network helps show where Rui Wu may publish in the future.

Co-authorship network of co-authors of Rui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Wu. A scholar is included among the top collaborators of Rui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Wu. Rui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xihao, Zhenxiang Dai, Yichao Liu, et al.. (2025). Computational investigation of Li-decorated B14 as a room temperature reversible energy storage medium. International Journal of Hydrogen Energy. 101. 1439–1447. 5 indexed citations
2.
Wu, Rui, Xinyou Zhang, Xinyi Xia, et al.. (2025). Effects of three different dietary β-gulcans supplementation on the microbiota composition and short-chain fatty acid production in mice. SHILAP Revista de lepidopterología. 11(1). 172–172.
3.
Oshi, Masanori, Akimitsu Yamada, Rui Wu, et al.. (2024). Breast cancer in adolescents and young adults has a specific biology and poor patient outcome compared with older patients. ESMO Open. 9(11). 103737–103737. 2 indexed citations
4.
Xu, Jinyi, Lihong Yang, You Zhang, et al.. (2024). Heart rate deceleration and acceleration capacities associated with circadian rhythm of blood pressure in essential hypertension. BMC Cardiovascular Disorders. 24(1). 257–257.
5.
Zhao, J., Huiying Zhou, Rui Wu, et al.. (2024). Biological aging accelerates hepatic fibrosis: Insights from the NHANES 2017–2020 and genome-wide association study analysis. Annals of Hepatology. 30(2). 101579–101579. 2 indexed citations
6.
Hurwitz, Stephanie N., Brian Lockhart, Özlem Önder, et al.. (2023). Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker. Modern Pathology. 36(7). 100170–100170. 3 indexed citations
7.
Huang, Rongxia, et al.. (2023). Construction of hub transcription factor–microRNAs–messenger RNA regulatory network in recurrent implantation failure. Journal of Assisted Reproduction and Genetics. 41(1). 3–13. 3 indexed citations
8.
Wu, Rui, Guang Yang, Robyn T. Sussman, et al.. (2022). Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms. Journal of Molecular Diagnostics. 25(2). 87–93. 7 indexed citations
9.
Lowe, Eric, Anne F. Reilly, Megan S. Lim, et al.. (2022). Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1. Journal of Clinical Oncology. 41(11). 2043–2053. 25 indexed citations
10.
Lowe, Eric, Anne F. Reilly, Megan S. Lim, et al.. (2021). Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1. Blood. 137(26). 3595–3603. 46 indexed citations
11.
Wu, Rui, Jiali Fang, Jun Arita, et al.. (2020). SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation. Journal of Biological Chemistry. 295(19). 6741–6753. 25 indexed citations
12.
Ma, Gui, Ang Gao, Yuan He, et al.. (2019). Zfhx3 is essential for progesterone/progesterone receptor signaling to drive ductal side-branching and alveologenesis in mouse mammary glands. Journal of genetics and genomics. 46(3). 119–131. 11 indexed citations
13.
Tögel, Lars, Rui Wu, Anderly C. Chüeh, et al.. (2018). DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis. Scientific Reports. 8(1). 1767–1767. 12 indexed citations
14.
Gao, Ang, Gui Ma, Ling Chen, et al.. (2018). LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway. Nature Communications. 9(1). 4180–4180. 54 indexed citations
15.
Wu, Rui, et al.. (2017). Effects of Tim-3 silencing on the viability of fibroblast-like synoviocytes and lipopolysaccharide-induced inflammatory reactions. Experimental and Therapeutic Medicine. 14(3). 2721–2727. 6 indexed citations
16.
Tögel, Lars, Anderly C. Chüeh, Aparna Jayachandran, et al.. (2016). Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells. Molecular Cancer Therapeutics. 15(6). 1217–1226. 74 indexed citations
17.
Wu, Rui, Na Wang, Min Li, Wenqiao Zang, & Yuming Xu. (2013). Experimental study on the facilitative effects of miR‐125b on the differentiation of rat bone marrow mesenchymal stem cells into neuron‐like cells. Cell Biology International. 37(8). 812–819. 7 indexed citations
18.
Wu, Rui, Yue Tang, Wenqiao Zang, et al.. (2013). MicroRNA-128 regulates the differentiation of rat bone mesenchymal stem cells into neuron-like cells by Wnt signaling. Molecular and Cellular Biochemistry. 387(1-2). 151–158. 29 indexed citations
19.
20.
Wu, Rui, et al.. (2004). Estimation of relative blood volume in head and neck squamous cell carcinomas. Journal of Neuroradiology. 31(3). 190–197. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Watanabe Breakdown of academic impact, for papers by S. Gururangan Breakdown of academic impact, for papers by Rachel Chiaroni-Clarke Breakdown of academic impact, for papers by Yan Yi Breakdown of academic impact, for papers by Hirotomo Tanaka Breakdown of academic impact, for papers by Meral Sakızlı Breakdown of academic impact, for papers by Renata Ferri Breakdown of academic impact, for papers by Susanna Mannisto Breakdown of academic impact, for papers by Signe Ledou Nielsen
Rankless by CCL
2026